New Treatments for Hodgkin Lymphoma Coming to ClinicsSandra Kear
Treatments and clinical burden among hodgkin lymphoma patients at high risk of relapse after autologous stem cell transplant: A literature reviewBonthapally, VAyyagari, RYang, HWu, E QShonukan, O
Burkitt lymphomais a form of non-Hodgkin's lymphomain whichcancerstarts in immune cells called B-cells. Recognized as a fast growing human tumor, Burkitt lymphoma is associated with impairedimmunityand is rapidly fatal if left untreated. However, intensivechemotherapycan achieve long-term survival in...
Bacterial infections, such as endocarditis (an infection of your heart's valves) Cancer Leukemia, a cancer in which abnormal blood cells take over healthy cells Lymphoma, a cancer of the lymph tissue, such as Hodgkin's disease Other causesof an enlarged spleen include: Inflammatory diseases such...
The outcome of 70 elderly patients aged 65 years or more (median, 71 years) with non-Hodgkin's lymphoma (NHL) treated between 1973 and 1981 with aggressive (AM) or conservative modalities (CM) was retrospectively evaluated. A significantly higher incidence of lethal and severe toxicity was ...
In HIV-positive patients who develop non-Hodgkin lymphoma (NHL), it is widely accepted that outcomes can be improved by combining antiretroviral therapy with treatments directed at NHL. The clinician's armamentarium now includes highly active antiretroviral therapy (HAART), standard chemotherapy ...
Messori A, Fadda V, Maratea D, Trippoli S. Treatments for non-Hodgkin lymphoma in HIV-positive patients: quantifying incremental benefit from 1993 to 2004 by meta-regression. Am J Hematol 2013;88(5):435.Messori A, Fadda V, Maratea D, Trippoli S (2013) Treatments for non-Hodgkin ...
These investigators found evidence for the role of an intact B-cell receptor signaling pathway in the sensitivity of cell lines to IPI-145, and efforts are under way to define specific biomarkers that identify patients with DLBCL who are sensitive to the drug. In addition, IPI-145 was ...
Improvements in Treatments for Hodgkin Lymphoma Over a 50-Year Period Lead to Fewer Second MalignanciesResponse to primary treatment in diffuse large B cell lymphoma (DLBCL) is highly predictive of long-term outcome. We evaluated the value of computed tomography (CT) findings relative to positron ...
New drugs and targeted treatments in Hodgkin鈥檚 lymphomaMariano Provencio